Skip to content

Price / earnings at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
24×+2.8×
IQVIA logo
IQVIAIQV
20.7×-2.6×
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
29.6×+7.3×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
26.4×
Simulations Plus logo
Simulations PlusSLP
80.2×+1.3×
Labcorp Holdings logo
Labcorp HoldingsLH
23.4×-3.3×

Other financials

Income statement

See full
Revenue$636.5M-2.3%
Gross profit$123.6M+6.1%
Operating income-$3.4M+99.3%
Net income-$23.6M+95.8%
EPS (diluted)-$0.25+96.0%

Balance sheet

See full
Cash & equivalents$147.5M+45.2%
Total debt$1.1B-13.1%
Total equity$525.9M-38.8%
Total assets$2.7B-14.0%

Cash flow

See full
Operating cash flow-$17.0M+86.3%
CapEx$8.0M+176%
Free cash flow-$25.0M+80.3%

Valuation

See full
Market cap$1.65B+247%
Enterprise value$2.62B+59.8%
P/S0.6×+0.4×

Profitability

See full
Gross margin18.9%-1.3pp
Operating margin-13.1%-4.1pp
Net margin-16.5%-5.0pp
FCF margin5.8%+1.7pp

Returns & leverage

See full
Return on equity-64.5%0.0pp
Debt / equity2.1×+0.6×
Current ratio0.9×0.0×

Where this comes from

Calculated from Fortrea Holdings Inc.’s reported figures.

Based on the most recent quarter.

The official record: Fortrea Holdings Inc.’s 10-Q, filed November 8, 2024, on SEC EDGAR. View the filing →

Ask your AI about Fortrea Holdings Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fortrea Holdings Inc.'s price / earnings?
Fortrea Holdings Inc. (FTRE) reported price / earnings of 44.6× in Q3 2023.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.